Trial Profile
A single dose, sequence-randomized, open-label, 2x2 crossover study to compare pharmacokinetics between pitavastatin and valsartan co-administration and Livalo fixed combination drug in healthy male subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Mar 2017
Price :
$35
*
At a glance
- Drugs Pitavastatin/valsartan (Primary) ; Pitavastatin; Valsartan
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register; KCT0000161).
- 04 Aug 2011 New trial record